DUBOIS-STRINGFELLOW NATHALIE (SVP-CHIEF DEVELOPMENT OFFICER) sold 51.0% of their position (345.94K shares) of SANGAMO THERAPEUTICS, INC on the open market
Open‑market sale worth $89.2K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/23/2026ACC: 0001947007-26-000010
Officer· SVP-CHIEF DEVELOPMENT OFFICER
Since Feb 2026
-345.94K
Net shares
Net seller
$89.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
345.94K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−345.94K
Price / share
$0.26
Trade value
$89.18K
% of position
51.0%
4/21/2026
678.71K→332.77K
Total
Net shares
−345.94K
Net value
-$89.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/21/2026 | S · Sale | −345.94K | $0.26 | $89.18K | 51.0% | 678.71K | 332.77K |
| Total | −345.94K | -$89.18K | ||||||
Derivative Transactions0
No derivative transactions reported